Cvi Holdings, LLC Kura Oncology, Inc. Transaction History

Cvi Holdings, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $896,800 - $1.27 Million	-60,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $894,368 - $1.2 Million	60,800 New	60,800 $1.2 Million
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $1.27 Million - $1.66 Million	-76,200 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $1.13 Million - $1.43 Million	76,200 New	76,200 $1.39 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.